Bauder-Wüst U - Search Results

1

68Ga-complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imaging.

Eder M, Schäfer M, Bauder-Wüst U, Hull WE, Wängler C, Mier W, Haberkorn U, Eisenhut M. Eder M, et al. Bioconjug Chem. 2012 Apr 18;23(4):688-97. doi: 10.1021/bc200279b. Epub 2012 Mar 13. Bioconjug Chem. 2012. PMID: 22369515

2

Cytosine deaminase and thymidine kinase gene therapy in a Dunning rat prostate tumour model: absence of bystander effects and characterisation of 5-fluorocytosine metabolism with 19F-NMR spectroscopy.

Corban-Wilhelm H, Hull WE, Becker G, Bauder-Wüst U, Greulich D, Debus J. Corban-Wilhelm H, et al. Gene Ther. 2002 Dec;9(23):1564-75. doi: 10.1038/sj.gt.3301834. Gene Ther. 2002. PMID: 12424609

3

Alkylating benzamides with melanoma cytotoxicity.

Wolf M, Bauder-Wüst U, Mohammed A, Schönsiegel F, Mier W, Haberkorn U, Eisenhut M. Wolf M, et al. Melanoma Res. 2004 Oct;14(5):353-60. doi: 10.1097/00008390-200410000-00004. Melanoma Res. 2004. PMID: 15457090

4

Alkylating benzamides with melanoma cytotoxicity: role of melanin, tyrosinase, intracellular pH and DNA interaction.

Wolf M, Bauder-Wüst U, Haberkorn U, Mier W, Eisenhut M. Wolf M, et al. Melanoma Res. 2005 Oct;15(5):383-91. doi: 10.1097/00008390-200510000-00006. Melanoma Res. 2005. PMID: 16179865

5

Fluorophor-labeled spermidine derivatives as fluorescent markers in optical tumor imaging.

Wolf M, Bauder-Wüst U, Pipkorn R, Eskerski H, Eisenhut M. Wolf M, et al. Bioorg Med Chem Lett. 2006 Jun 15;16(12):3193-6. doi: 10.1016/j.bmcl.2006.03.046. Epub 2006 Apr 18. Bioorg Med Chem Lett. 2006. PMID: 16621552

6

Alkylating benzamides with melanoma cytotoxicity: experimental chemotherapy in a mouse melanoma model.

Wolf M, Eskerski H, Bauder-Wüst U, Haberkorn U, Eisenhut M. Wolf M, et al. Melanoma Res. 2006 Dec;16(6):487-96. doi: 10.1097/01.cmr.0000232294.14408.6a. Melanoma Res. 2006. PMID: 17119449

7

Polyamine-substituted gadolinium chelates: a new class of intracellular contrast agents for magnetic resonance imaging of tumors.

Wolf M, Hull WE, Mier W, Heiland S, Bauder-Wüst U, Kinscherf R, Haberkorn U, Eisenhut M. Wolf M, et al. J Med Chem. 2007 Jan 11;50(1):139-48. doi: 10.1021/jm061003a. J Med Chem. 2007. PMID: 17201417

8

Role of acidic cell organelles in the higher nonmelanoma retention of melanoma markers based on N-(2-dialkylaminoethyl)benzamides and the cytotoxicity of alkylating benzamides.

Wolf M, Bauder-Wüst U, Eskerski H, Bauer C, Eisenhut M. Wolf M, et al. Melanoma Res. 2007 Apr;17(2):61-73. doi: 10.1097/CMR.0b013e328042bb1d. Melanoma Res. 2007. PMID: 17496781

9

Therapy of thyroid carcinoma with the histone deacetylase inhibitor MS-275.

Altmann A, Eisenhut M, Bauder-Wüst U, Markert A, Askoxylakis V, Hess-Stumpp H, Haberkorn U. Altmann A, et al. Eur J Nucl Med Mol Imaging. 2010 Dec;37(12):2286-97. doi: 10.1007/s00259-010-1573-3. Epub 2010 Aug 3. Eur J Nucl Med Mol Imaging. 2010. PMID: 20680269

10

Multivalent cyclic RGD ligands: influence of linker lengths on receptor binding.

Kubas H, Schäfer M, Bauder-Wüst U, Eder M, Oltmanns D, Haberkorn U, Mier W, Eisenhut M. Kubas H, et al. Nucl Med Biol. 2010 Nov;37(8):885-91. doi: 10.1016/j.nucmedbio.2010.06.005. Epub 2010 Jul 24. Nucl Med Biol. 2010. PMID: 21055618

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters